Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1975-4-23
|
pubmed:language |
nor
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0029-2001
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-40
|
pubmed:dateRevised |
2008-7-16
|
pubmed:meshHeading |
pubmed-meshheading:1111161-Drug Combinations,
pubmed-meshheading:1111161-Drug Contamination,
pubmed-meshheading:1111161-Drug Evaluation,
pubmed-meshheading:1111161-Drug Therapy,
pubmed-meshheading:1111161-Drug Utilization,
pubmed-meshheading:1111161-Drug and Narcotic Control,
pubmed-meshheading:1111161-Norway,
pubmed-meshheading:1111161-Pharmacy and Therapeutics Committee
|
pubmed:year |
1975
|
pubmed:articleTitle |
[Criteria for choice of preparations in a drug committee].
|
pubmed:publicationType |
Journal Article
|